Abstract
We present a general theory of infection spreading, which directly follows from conservation laws and takes as inputs the probability density functions of latent times. The derivation of the theory substantially differs from Kermack and McKendrick (1927) argument, which instead was based on the concept of removal rates. We demonstrate the formal equivalence of the two approaches, but our theory provides a clear interpretation of the kernels of the integro-differential equations governing the infection spreading in terms of survival function of the latent times distributions. This aspect was never captured before. Real distributions of latent times can be, then, employed, thus overcoming the limitations of standard SIR, SEIR and other similar models, which implicitly make use of exponential or exponential-related distributions. SIR and SEIR-type models are, in fact, a subclass of the theory here presented. We show that beside the infection rate ν, the joint probability density function pEI (τ, τ1) of latent times in the exposed and infectious compartments governs the infection spreading. Assuming that the number of infected individuals is negligible compare to the entire population, we were able to study the stability of the dynamical system and provide the general solution of equations in terms characteristic functions of the probability distribution of latent times. We present asymptotic solutions for the case R0 = 1 and demonstrate that the moments of the latent times distribution govern the rate of disease spreading in this case. The present theory is employed to simulate the diffusion of COVID-19 infection in Italy during the first 120 days. The estimated value of the basic reproduction number is R0 ≈ 3.5, in very good agreement with existing data.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
We have made minor changes to correct typos in one formula and figure captions.
Data Availability
All data produced in the present study are available upon reasonable request to the authors